US 9040673B2
· Hecht et al.
· 2015
[cited by applicant]
US 9827252B2
· Zon
· 2017
[cited by examiner]
US 20030229082A1
· James et al.
· 2003
[cited by applicant]
US 20080033000A1
· Chang et al.
· 2008
[cited by applicant]
US 20150329498A1
· Romero et al.
· 2015
[cited by applicant]
US 20240299391A1
· Doulatov et al.
· 2024
[cited by applicant]
GB 716230A
· 1954
[cited by applicant]
WO WO2003062388A2
· 2003
[cited by applicant]
WO WO2003062388A3
· 2004
[cited by applicant]
WO 2009040512A2
· 2009
[cited by applicant]
WO WO2009040512A3
· 2009
[cited by applicant]
WO 2010033643A2
· 2010
[cited by applicant]
WO WO2010033643A3
· 2010
[cited by applicant]
WO WO2011019995A2
· 2011
[cited by examiner]
WO WO2013138101A2
· 2013
[cited by examiner]
WO 2013181742A1
· 2013
[cited by applicant]
WO WO2018013761A1
· 2018
[cited by applicant]
WO WO2018226230A1
· 2018
[cited by applicant]
Doulatov et al. “Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors”; Feb. 8, 2017, Science Translational Medicine, 9(376): eaah5645.
[cited by applicant]
Fujii et al “Studies on the Syntheses of Phenothiazine Derivatives. II. On the Reduction of 10-ß-Cyanoethylphenothiazines”, JStage vol. 76 pp. 640-644 (1956).
[cited by applicant]
Heijnen et al., “Ribosomal protein mutations induce autophagy through S6 kinase inhibition of the insulin pathway”, PLoS Genetics 10(5): e1004371 15 pages (2014).
[cited by applicant]
Hilinksi et al., “Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability”, Bioorganic & Medicinal Chemistry Letters 22(9): 3244-3247 (2012).
[cited by applicant]
Horig et al., “From bench to clinic and back: Perspective on the 1
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US17/36520 mailing date Oct. 18, 2017.
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US17/41851 mailing date Nov. 9, 2017.
[cited by applicant]
Macari et al., “Calmodulin Inhibition Rescues the Effects of Ribosomal Protein Deficiency in in Vitro and In Vivo Diamond Blackfan Anemia Models.” Blood 126(23):672 (2015).
[cited by applicant]
Pearce et al., “Characterisation of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)”, Biochemical Journal 431:245-255 (2010).
[cited by applicant]
Schafer et al., “Failure is an option: learning from unsuccessful proof-of-concept trials”. Drug Discovery Today. Nov. 2008, 13, 913-916.
[cited by applicant]
Supplementary European Search Report for EP Application No. 17828436.0 dated Jun. 23, 2020.
[cited by applicant]
Supplementary Partial European Search Report for EP Application No. 17828436.0 dated Feb. 14, 2020.
[cited by applicant]
Vlachos et al., “Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference.” British Journal of Haematology 142(6) : 859-876 (2008).
[cited by applicant]
Extended European Search Report for EP Application No. 24174240.2 dated Oct. 16, 2024.
[cited by applicant]
Database Biosis [Online] Biosciences Information Service, Philadelphia, PA, US; Dec. 2015 (Dec. 2015), Macari Elizabeth R et al: “Calmodulin Inhibition Rescues the Effects of Ribosomal Protein Deficiency in in Vitro and…
[cited by applicant]
Fujii et al. “Synthesis of Phenothiazine Derivatives. II. Reduction of 10-(β-Cyanoethy) Phenothiazines” Yakugaku Zasshi vol. 76:640-644 (1956).
[cited by applicant]
Heijnen et al. “Ribosomal protein mutations induce autophagy through S6 kinase inhibition of the insulin pathway.” PLoS Genetics 10(5): e1004371 pp. 1-15 (2014).
[cited by applicant]
Hilinski et al. “Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability.” Bioorganic & Medicinal Chemistry Letters 22(9): 3244-3247 (2012).
[cited by applicant]
Pearce et al., “Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1)”, Biochemical Journal 431:245-255 (2010).
[cited by applicant]